Carbon Sprinting Spiked-Shoes Trial
CS3T
Carbon " Super Spikes " Performances on Sprint Acceleration : Just Use it? A Multiple N-of-1 Trial. A Multiple N-of-1 Trial in Healthy Athletes
1 other identifier
interventional
21
1 country
1
Brief Summary
Objectives : To determine intra and inter-subject sprinting performance modifications with trademarked Carbon-made spiked-Shoes (CS) compared to usual carbon-free ones (Standard spiked-Shoes-SS). Methods : Design. Multiple N-of-1 trial (Alternating Treatments Design), with block randomisation and double blind procedure. For each participants, sixteen repetitions of 30m-sprint are applied either with CS or SS, in random order for each repetition, during a 3h session a day. Blind procedures are reached by applying a dark sleeve cover on each shoes, and by separating raters from investigators. Patients. Regional to National healthy sprinting athletes (750 IAAF/WA points), affiliated to the French Athletics Federation among the South Regional Athletic League (Comité du Var-FFA), are recruited as volunteers, with their own CS (from the same brand for homogeneity and generalisation concerns) and SS. Main criteria. Time on a 30-meters sprint, with Force-Velocity Profiling (FVP) procedure, using Stalker Sport radar. Secondary outcome measures. F0, V0, Vmax, Pmax , DRP and other standard FVP parameters, also measured with MySprint software; morphometric and cinematic data ; mean price difference between the two models. Statistical analyses. A block randomisation model will be applied to check for the randoms size; variance analysis with a mixt linear model will be applied for group and confounding factors analysis. Student-T test and NAP will be applied for intra-individuals analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2023
CompletedFirst Posted
Study publicly available on registry
May 31, 2023
CompletedStudy Start
First participant enrolled
June 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 6, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 6, 2023
CompletedNovember 2, 2023
October 1, 2023
2 months
May 19, 2023
October 30, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
30m-sprint Time
16 x30m-sprint per subject
in a 3 hour session a day
Study Arms (2)
Carbon sprinting Super-spikes
EXPERIMENTALTrademarked Carbon Spiked-Shoes, from one Trademark only to ensure generalization concerns, is used alternatively with standard carbon-free spiked-shoes, for 8 repetitions of 30m-sprint each, separated by 10 minutes rest each.
Standard sprinting carbon-free spiked-shoe
ACTIVE COMPARATORInterventions
Trademarked Carbon Spiked-Shoes, from one Trademark only to ensure generalization concerns, is used alternatively with standard carbon-free spiked-shoes, for 8 repetitions of 30m-sprint each, separated by 10 minutes rest each.
Eligibility Criteria
You may qualify if:
- Sprinting athletes affiliated to the French Athletic Federation among the Var Athletics Comity
- Sprint Performance \> 750pts IAAF/WA (50 to 400m)
You may not qualify if:
- Age\<15
- Ongoing Injury
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hopital Leon Berard
Hyères, Var, 83400, France
Related Publications (4)
Samozino P, Rabita G, Dorel S, Slawinski J, Peyrot N, Saez de Villarreal E, Morin JB. A simple method for measuring power, force, velocity properties, and mechanical effectiveness in sprint running. Scand J Med Sci Sports. 2016 Jun;26(6):648-58. doi: 10.1111/sms.12490. Epub 2015 May 21.
PMID: 25996964BACKGROUNDEdouard P, Lahti J, Nagahara R, Samozino P, Navarro L, Guex K, Rossi J, Brughelli M, Mendiguchia J, Morin JB. Low Horizontal Force Production Capacity during Sprinting as a Potential Risk Factor of Hamstring Injury in Football. Int J Environ Res Public Health. 2021 Jul 23;18(15):7827. doi: 10.3390/ijerph18157827.
PMID: 34360125BACKGROUNDNagahara R, Kanehisa H, Fukunaga T. Influence of shoe sole bending stiffness on sprinting performance. J Sports Med Phys Fitness. 2018 Dec;58(12):1735-1740. doi: 10.23736/S0022-4707.17.07834-3. Epub 2017 Oct 27.
PMID: 29083127BACKGROUNDBernuz B, Laujac S, Sirial C, Auffret S, Preda C, Slawinski J, Millot B, Pradon D, Coudrat L, Gavarry O. Effect of Advanced Footwear Technology Spikes on Sprint Acceleration: A Multiple N-of-1 Trial. Sports Med Open. 2024 Aug 30;10(1):92. doi: 10.1186/s40798-024-00758-w.
PMID: 39214886DERIVED
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Each participant is self-blinded, but also blinded to other participants ' alternative order
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr Bernuz Benjamin; PMR; MD-MSc
Study Record Dates
First Submitted
May 19, 2023
First Posted
May 31, 2023
Study Start
June 3, 2023
Primary Completion
August 6, 2023
Study Completion
August 6, 2023
Last Updated
November 2, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP
- Time Frame
- as soon as leading article is published
- Access Criteria
- cf Plan Description
Data will be available upon reasonable request. For the Editorial office of the corresponding relevant editor; for meta-analyses needs, or for other detailed requests. From all types, with de-identified files (Morphometric, cinematic and FVP data, Statistical Analysis, etc..). Via a controlled access repositories, such as clinicalstudydatarequest.com, the YODA project, or Vivli.